Table 4.
Threshold analyses for detection of parameters of kidney disease in patients with type 2 diabetes, by race
Diagnostic performance | African American | European American | ||
---|---|---|---|---|
UACR >300 mg/g | eGFR <60 ml/min/1.73m2 | UACR >300 mg/g | eGFR <60 ml/min/1.73m2 | |
Cut-point | 32.5 | 37.6 | 46.9 | 44.4 |
AUC | 0.616 (0.556, 0.675) | 0.744 (0.701, 0.786) | 0.644 (0.57, 0.719) | 0.74 (0.682, 0.798) |
Sensitivity | 0.696 (0.606, 0.774) | 0.693 (0.626, 0.753) | 0.617 (0.49, 0.729) | 0.686 (0.599, 0.762) |
Specificity | 0.511 (0.463, 0.558) | 0.698 (0.647, 0.745) | 0.642 (0.575, 0.703) | 0.729 (0.654, 0.793) |
NPV | 0.835 (0.796, 0.878) | 0.872 (0.848, 0.897) | 0.834 (0.79, 0.883) | 0.874 (0.845, 0.906) |
PPV | 0.322 (0.286, 0.354) | 0.434 (0.384, 0.476) | 0.364 (0.295, 0.421) | 0.458 (0.376, 0.52) |
ESC=electrochemical skin conductance; UACR=urine albumin:creatinine ratio; eGFR=estimated glomerular filtration rate; AUC=area under the curve; NPV=negative predicted probability; PPV=positive predicted probability